Strong Buy Rating for Editas Medicine: Promising Pipeline and Strategic IP Position Drive Optimism
TipRanksMar 1 01:17 ET
Editas Medicine: Balanced Prospects and a Hold Rating With Modest Price Target Increase
TipRanksMar 1 01:06 ET
The Latest Analyst Ratings For Editas Medicine
BenzingaFeb 29 12:00 ET
Oppenheimer Sticks to Its Hold Rating for Editas Medicine (EDIT)
TipRanksFeb 29 08:07 ET
Hold Rating on Editas Medicine Pending Clinical Trial Outcomes and Market Differentiation Potential
TipRanksFeb 29 05:43 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Schrodinger (SDGR), Editas Medicine (EDIT) and MacroGenics (MGNX)
TipRanksFeb 29 02:51 ET
TD Cowen Sticks to Its Buy Rating for Editas Medicine (EDIT)
TipRanksFeb 28 12:15 ET
Editas Medicine Analyst Ratings
BenzingaFeb 27 13:01 ET
Buy Rating for Editas Medicine Backed by Strong SCD Program and Promising Clinical Developments
TipRanksJan 9 05:17 ET
RBC Capital Keeps Their Hold Rating on Editas Medicine (EDIT)
TipRanksJan 5 20:47 ET
RBC Boosts Price Target on Editas Medicine to $11 From $8, Keeps Sector Perform Rating
MT NewswiresJan 3 07:59 ET
Editas Medicine Analyst Ratings
BenzingaDec 12, 2023 10:11 ET
Analysts Offer Insights on Healthcare Companies: IN8bio (INAB) and Editas Medicine (EDIT)
TipRanksNov 8, 2023 01:50 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Editas Medicine (EDIT), Corvus Pharmaceuticals (CRVS) and AC Immune SA (ACIU)
TipRanksNov 8, 2023 01:41 ET
Truist Financial Keeps Their Buy Rating on Editas Medicine (EDIT)
TipRanksNov 6, 2023 21:26 ET
RBC Capital Keeps Their Hold Rating on Editas Medicine (EDIT)
TipRanksNov 6, 2023 07:07 ET
Hold Rating on Editas Medicine's Stock: A Balanced View on Promising Developments and Market Challenges
TipRanksNov 5, 2023 20:57 ET
Positive Outlook for Editas Medicine: Progress in Clinical Trials and Proactive Off-Target Analysis Bolsters Buy Rating
TipRanksNov 5, 2023 18:58 ET
Promising Clinical Trials and Strong Financial Position Boost Editas Medicine's Buy Rating: An Analysis
TipRanksNov 3, 2023 15:55 ET
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Editas Medicine (EDIT) and Revolution Medicines (RVMD)
TipRanksOct 24, 2023 08:21 ET
No Data
No Data